ResearcherCairo UniversityNo recent work listed

Sahar M. Abou‐Seri

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5073430332. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2022: 1 paper

Papers 1

Identification of novel piperazine-tethered phthalazines as selective CDK1 inhibitors endowed with in vitro anticancer activity toward the pancreatic cancer. Last author DOI 10.1016/j.ejmech.2022.114704 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Laila Akl · 1 shared paper, 2022 · strength 0.16
- Paper Identification of novel piperazine-tethered phthalazines as selective CDK1 inhibitors endowed with in vitro anticancer … DOI 10.1016/j.ejmech.2022.114704 ↗
Wagdy Mohamed Eldehna · 1 shared paper, 2022 · strength 0.16
- Paper Identification of novel piperazine-tethered phthalazines as selective CDK1 inhibitors endowed with in vitro anticancer … DOI 10.1016/j.ejmech.2022.114704 ↗
Tamer M. Ibrahim · 1 shared paper, 2022 · strength 0.16
- Paper Identification of novel piperazine-tethered phthalazines as selective CDK1 inhibitors endowed with in vitro anticancer … DOI 10.1016/j.ejmech.2022.114704 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.